Prostate Cancer

News and new technology innovations concerning how imaging technology can help diagnose and treat prostate cancer can be found on this channel.

prostate cancer, PET imaging, Johns Hopkins, Daniel Thorek, 11B6 antibody

Uptake of 89Zr-11B6 in the prostate of a transgenic mouse with prostate cancer. Image courtesy of Daniel Thorek

News | Prostate Cancer | November 30, 2016
New Imaging Method Can Detect, Monitor and Guide Treatment for Prostate Cancer
November 30, 2016 — An international group of researchers report success in mice of a method of using...
read more
Augmenix, SpaceOAR System, prostate cancer, new CPT code, AMA, American Medical Association
Technology | Prostate Cancer | November 10, 2016
Augmenix Announces New Category 1 CPT Code for Periprostatic Implantation of Biodegradable Material
November 10, 2016 — Augmenix Inc. announced that the American Medical Association (AMA) has granted a Category I,...
read more
News | Prostate Cancer | November 02, 2016
More American Men with Early-Stage Prostate Cancer Could Opt Out of Immediate Treatment
November 2, 2016 — A new report on Swedish men with non-aggressive prostate cancer suggests a lot more American men...
read more
Augmenix, SpaceOAR System, prostate cancer, three-year clinical data results, ASTRO 2016
News | Prostate Cancer | October 27, 2016
Augmenix Announces Positive Three-year SpaceOAR Clinical Trial Results
October 27, 2016 — Augmenix Inc. announced the three-year results from the SpaceOAR System...
read more
intermediate-risk prostate cancer, brachytherapy versus external beam therapy, radiation therapy, RT, ASTRO 2016
News | Brachytherapy Systems | October 25, 2016
Intermediate-Risk Prostate Cancer May be Well-Controlled with Brachytherapy Alone
October 25, 2016 — For men with intermediate-risk...
read more
Axumin, fluciclovine F-18, PET agent, Phase 3 study, recurrent prostate cancer detection, Blue Earth Diagnostics
News | Prostate Cancer | October 25, 2016
Axumin (Fluciclovine F-18) PET Tracer Effective in Detecting Recurrent Prostate Cancer
October 25, 2016 — Blue Earth Diagnostics Ltd. announced the peer-reviewed publication of results from a Phase 3...
read more
prostate cancer, SBRT, stereotactic body radiotherapy, ASTRO 2016 study, Robert Meier, control, side effects, toxicity
News | Radiation Therapy | October 06, 2016
SBRT Offers High Prostate Cancer Control, Low Toxicity in Fewer Treatments
October 6, 2016 — High-dose stereotactic body radiotherapy (SBRT) for men newly diagnosed with low- or intermediate-...
read more
prostate cancer, ProtecT trial findings, ASTRO 2016, radiation therapy
News | Radiation Therapy | October 03, 2016
Prostate Cancer Patients Encouraged to Weigh Long-term Impact of Treatment Options
September 29, 2016 — The American Society for Radiation Oncology (ASTRO) extended its congratulations to the authors...
read more
prostate cancer, hormone therapy, cardiac risk factors, Yale Cancer Center study, ASTRO 2016
News | Cardio-oncology | September 28, 2016
Cardiac Risk a Factor When Considering Hormonal Therapy for Prostate Cancer
September 28, 2016 — In a recent study, a Yale Cancer Center team determined that men who received hormonal therapy for...
read more
prostate cancer, hypofractionated radiationt therapy, accelerated RT, side effects, treatment time, ASTRO 2016, NRG Oncology/RTOG 0415
News | Prostate Cancer | September 27, 2016
Hypofractionated Radiotherapy Reduces Treatment Time with Comparable Side Effects for Prostate Cancer Patients
September 27, 2016 — For men with early stage, low-risk...
read more
prostate cancer, novel intrinsic subtypes, study, ASTRO 2016
News | Prostate Cancer | September 26, 2016
Three Novel Intrinsic Subtypes of Prostate Cancer Identified
September 26, 2016 — In the largest study of its kind to date, researchers have identified and validated three distinct...
read more
prostate cancer, hypofractionated radiation therapy, HYPO-RT-PC trial, ASTRO 2016
News | Prostate Cancer | September 26, 2016
Extremely Hypofractionated Radiotherapy Shows Promising Toxicity Results for Intermediate-Risk Prostate Cancer
September 26, 2016 — For men with intermediate-risk...
read more
ASTRO 2016 annual meeting, clinical trials and research, press program, radiation therapy
News | Radiation Therapy | September 07, 2016
ASTRO Announces Featured Clinical Trials and Research for 2016 Annual Meeting
September 7, 2016 — The American Society for...
read more
Axumin, fluciclovine F-18 injection, first injection, Northside Hospital Atlanta
News | Radiopharmaceuticals and Tracers | September 07, 2016
First Prostate Cancer Patients Imaged With Axumin (Fluciclovine F-18) Tracer at Atlanta's Northside Hospital
September 7, 2016 — Blue Earth Diagnostics announced that the first post-U.S. Food and Drug Administration (FDA)...
read more
MRI, prostate cancer, zinc, UT Southwestern Medical Center study
News | Magnetic Resonance Imaging (MRI) | August 23, 2016
Novel MRI Technique Distinguishes Healthy Prostate Tissue From Cancer Using Zinc
August 23, 2016 — A novel ...
read more
high-risk prostate cancer, radical local treatment, Umea University Sweden study, mortality
News | Prostate Cancer | August 16, 2016
Radical Treatment and Examination Combined Can Halve Prostate Cancer Mortality
August 16, 2016 — High-risk prostate cancer...
read more
PRI-MUS protocol, ExactVu micro-ultrasound, prostate cancer, lesion identification, The Journal of Urology study

ExactVu micro-ultrasound system image courtesy of Exact Imaging.

News | Prostate Cancer | August 08, 2016
Initial Results of PRI-MUS Micro-Ultrasound Protocol Published
July 28, 2016 — Exact Imaging announced that The Journal of Urology has published the initial results supporting the...
read more
metastatic prostate cancer incidence, Northwestern Medicine study, Edward Schaeffer, Adam Weiner
Feature | Prostate Cancer | July 25, 2016
Metastatic Prostate Cancer Cases Skyrocket
July 25, 2016 — The number of new cases of metastatic...
read more
photoacoustic imaging

Images of prostate cells captured through photoacoustic imaging. Top: cancer cells that express the targeted cancer marker, PSMA; bottom: cells that lack PSMA. A research team led by Kent Nastiuk of Roswell Park Cancer Institute has published new evidence that this approach can be a useful tool in monitoring and selecting treatments for many cancers.

News | Prostate Cancer | July 15, 2016
Photoacoustic Imaging Is Promising Option for Noninvasive Monitoring of Prostate Cancer
While active surveillance is often recommended for patients with nonaggressive...
read more
PET, mpMRI, prostate cancer detection, targeted biopsies, University of Michigan study, Morand Piert

The figure shows a Gleason 3+4 prostate cancer (arrows) as identified on T2-weighted (A) and diffusion-weighted (B) MRI, F-18-choline PET (C), as well as PET/MRI (D).

News | Prostate Cancer | July 14, 2016
Study Suggests PET-MR One-Stop Imaging Test to Detect Prostate Cancer
July 14, 2016 — Adding F-18-choline positron...
read more
© Copyright Scranton Gillette Communications. All Rights Reserved.